Autobio Diagnostics Co., Ltd.
603658
Rang in Aktien
#4904
Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical... Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical diagnostic products, from their initial research and development to manufacturing and market distribution. Their diverse offerings encompass a range of reagents for immunoassay, biochemistry, microbiology, and in-vitro diagnostics (IVD). Additionally, they provide advanced automated and semi-automated instrumentation, alongside comprehensive medical laboratory solutions. Notable immunoassay products include the AutoLumo A2000 Plus automatic chemiluminescence immunoassay analyzer, automated microplate chemiluminescent enzyme immunoassays, LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Within their microbiology division, they offer automated blood culture systems, blood culture bottles, AUTOMIC strips, and mycoplasma IES. Founded in 1998, the company originally operated as Lifeclone Diagnostics Co., Ltd. before adopting its current name, Autobio Diagnostics Co., Ltd., in 2003. Headquartered in Zhengzhou, China, it functions as a subsidiary of Zhengzhou Auto Industrial Co., Ltd.
Aktienkurs
$5.15
Zuletzt synchronisiert: 2026-10-22
Marktkapitalisierung
$2.94B
Veränderung (1 Tag)
0.97%
Veränderung (1 Jahr)
-5.80%
Land
CN
Handel Autobio Diagnostics Co., Ltd. (603658)
Kategorie
Healthcare
P/S-Verhältnis für Autobio Diagnostics Co., Ltd. (603658)
P/S-Verhältnis zum October 2026 TTM: 4.65
Laut den neuesten Finanzberichten und dem Aktienkurs von Autobio Diagnostics Co., Ltd. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 4.65. Am Ende des Jahres 2024 lag das P/S-Verhältnis bei 5.63.
P/S-Verlauf für Autobio Diagnostics Co., Ltd. von 2011 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 4.65 | -2.85% |
| 2025 | 4.79 | -15.01% |
| 2024 | 5.63 | -23.73% |
| 2023 | 7.38 | -9.15% |
| 2022 | 8.13 | -5.17% |
| 2021 | 8.57 | -59.04% |
| 2020 | 20.93 | 38.52% |
| 2019 | 15.11 | 50.68% |
| 2018 | 10.03 | -35.35% |
| 2017 | 15.51 | -30.99% |
| 2016 | 22.47 | 104.13% |
| 2015 | 11.01 | -21.97% |
| 2014 | 14.11 | -26.83% |
| 2013 | 19.28 | -24.00% |
| 2012 | 25.37 | -43.23% |
| 2011 | 44.69 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| 5.29 | 13.76% |
US
|
|
| 6.43 | 38.09% |
US
|
|
| 21.32 | 358.07% |
US
|
|
| 6.53 | 40.27% |
CN
|
|
| 6.80 | 46.10% |
US
|
